Antiviral Properties of Silver Nanoparticles against SARS-CoV-2: Effects of Surface Coating and Particle Size

Qinghao He1, Jing Lu2, Nian Liu3

  • 1State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.

Insights

Silver nanoparticles (AgNPs) show strong potential in combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Different AgNP types demonstrated varying virucidal effects, with 50-nm BPEI being the most effective against the virus in vitro.

Area of Science:

  • Nanotechnology
  • Virology
  • Materials Science

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, necessitates novel therapeutic and preventative strategies due to emerging mutant strains.
  • Effective prevention of SARS-CoV-2 transmission in both public and healthcare settings is crucial to mitigate infection rates.
  • Silver nanoparticles (AgNPs) have demonstrated promising virucidal properties, suggesting their potential application against viral pathogens.

Purpose of the Study:

  • To evaluate the in vitro virucidal activity and safety of ten distinct types of silver nanoparticles (AgNPs) against SARS-CoV-2.
  • To determine how variations in AgNP surface modifications and particle sizes influence their efficacy in inhibiting SARS-CoV-2.
  • To establish a correlation between AgNP properties and their antiviral potential.

Main Methods:

  • In vitro assessment of virucidal activity using ten different types of AgNPs with varying surface modifications and particle sizes.
  • Exposure of cells to SARS-CoV-2 in the presence of different AgNPs to evaluate inhibition.
  • Analysis of the relationship between AgNP characteristics (e.g., potential difference) and observed virucidal effects.

Main Results:

  • All tested AgNPs exhibited inhibitory effects against SARS-CoV-2 in vitro.
  • Significant differences in virucidal efficacy were observed among AgNPs based on their surface modifications and particle sizes.
  • The 50-nm BPEI AgNPs demonstrated the strongest antiviral activity against SARS-CoV-2.
  • A positive correlation was found between the efficacy of AgNPs and their potential difference (R² = 0.82).

Conclusions:

  • AgNPs possess significant potential as broad-spectrum antiviral agents, offering a promising avenue for developing new therapeutics against SARS-CoV-2.
  • The specific surface modifications and particle sizes of AgNPs critically influence their virucidal effectiveness.
  • AgNPs could serve as a viable strategy to interrupt viral transmission routes, functioning as external materials or potential medicinal agents, especially in light of increasing drug resistance.